The EACC is delighted to welcome Consul member Guerbet.
Guerbet builds lasting relationships so that it enables people to live better. The Company is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging. A pioneer since 95 years in the field of contrast media with over 2,600 people globally, Guerbet is continuously innovating with 10% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €712 million in revenue in 2020.
For more information, please visit www.guerbet.com.